Sonde Health announces it has been selected by AFWERX for a SBIR Phase II contract in the amount of $1,215,606 focused on Sonde Mental Fitness to address the most pressing challenges in the Department of the Air Force (DAF).
Read More
Burnout is difficult to detect, and the best recourse is taking preemptive action before you hit the wall. Now, a new and non-invasive technology from Sonde Health helps detect signs of burnout through your voice.
Read More
Sonde’s vocal biomarker can either pick up on a user's voice passively, so long as the app is open on a phone, or actively with a 30-second audio message once a day.
Read More
Non-invasive health detection and monitoring technology analyzes vocal biomarkers to indicate a user's ongoing cognitive efficiency
Read More
Sonde Health and KT Corporation (KT) have agreed to collaborate on a next-generation mental health management solution.
Read More
Discover how Sonde is helping digital health firms enact behavioral change in the fight against chronic disease.
Read More
Learn how Sonde Health's vocal biomarker technology enhances frontline worker productivity by proactively monitoring stress and mental wellbeing in a non-invasive, cost-effective way.
Read More
We are pleased to announce that a new study has validated the effectiveness of our Mental Fitness Vocal Biomarker (MFVB) and the research has been published in the peer-reviewed journal, Frontiers in Psychiatry. Our latest study has demonstrated the remarkable capability of our MFVB platform to accurately discern individuals' mental health symptoms based on short recordings of their voice.
Read More
Our new study published in Frontiers in Psychiatry points to mental fitness vocal biomarkers (MFVB) as a promising approach to support mental health monitoring, engagement, and care.
Read More
Leading enterprise vocal biomarker company Sonde Health has been selected by AFWERX for a Phase I Small Business Innovation Research (SBIR) award in the amount of $71,166, focused on utilizing Sonde Mental Fitness to address the most pressing challenges in the Department of the Air Force (DAF).
Read More
Leading enterprise vocal biomarker company Sonde Health has partnered with Together, an AI-based health assistant, to provide enhanced mental health detection and monitoring through its new Mental Vitals feature. This collaboration integrates Sonde’s pioneering technology into the Together app, allowing users to access advanced voice analysis for early detection of symptoms related to depression and anxiety. Launched only a month ago, more than 20% of Together’s daily users are already using Sonde-powered Mental Vitals.
Read More
BOSTON, MA — May 23, 2023 — Sonde Health, a health technology company committed to bringing accessible health monitoring to everyone, has revealed new research that demonstrates the ability of its respiratory responsive vocal biomarker (RRVB) machine learning model to differentiate patients with COVID-19 from healthy individuals with about 70% accuracy.
Read More
Hidden away in our voices are signals that may hold clues to how we’re doing, what we’re feeling and even what’s going on with our physical health. Now, AI systems tasked with analyzing these signals are moving into healthcare.
Read More
Sonde Health, a health technology company committed to bringing accessible health monitoring to everyone, in conjunction with the Massachusetts General Hospital (MGH) Frontotemporal Disorders (FTD) Unit, has been selected by the Massachusetts Artificial Intelligence and Technology Center for Connected Care in Aging & Alzheimer’s Disease (MassAITC) to lead a pilot study focused on leveraging vocal biomarkers for remote detection and monitoring of mild cognitive impairment in the home environment.
Read More
By David Liu, CEO Sonde Health December 8th, 2022
I am beyond excited to share the latest major milestone in Sonde’s journey to making preventive care possible through voice-powered health monitoring.
We have raised $19.25 million in Series B funding, led by Partners Investment, with NEOM Company and KT Corporation participating. Our existing investors, co-founder PureTech Health, M Ventures, MP Healthcare Venture Management, Neoteny and Evidity Health Capital all came back and invested in this round.
BOSTON – Dec. 8, 2022 – Sonde Health, a health technology company committed to bringing accessible health monitoring to everyone, has raised a $19.25 million Series B investment round led by Partners Investment, with participation from NEOM Company, KT Corporation, and existing investors, including co-founder PureTech Health and M Ventures. The company has raised $35.25 million in total and will use the funding to drive its global commercial growth, deepen its respiratory and mental health monitoring technologies, and build capabilities for additional health conditions.
Read More